Difference between revisions of "Tolcher AW, et al. J. Clin. Oncol. (2012) cited as Ref 584 in DOI: 10.1038/s41392-020-0110-5 (Q9847)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 30, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: Page(s) (P105): 2348-2353, #quickstatements; #temporary_batch_1590074839150)
 
(One intermediate revision by the same user not shown)
Property / title
 +
Phase I study of RO4929097 a gamma secretase inhibitor of Notch signaling in patients with refractory metastatic or locally advanced solid tumors (English)
Property / title: Phase I study of RO4929097 a gamma secretase inhibitor of Notch signaling in patients with refractory metastatic or locally advanced solid tumors (English) / rank
 +
Normal rank
Property / Page(s)
 +
2348-2353
Property / Page(s): 2348-2353 / rank
 +
Normal rank

Latest revision as of 15:46, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Tolcher AW, et al. J. Clin. Oncol. (2012) cited as Ref 584 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Tolcher AW
    0 references
    0 references
    2012
    0 references
    J. Clin. Oncol.
    0 references
    30
    0 references
    Phase I study of RO4929097 a gamma secretase inhibitor of Notch signaling in patients with refractory metastatic or locally advanced solid tumors (English)
    0 references
    2348-2353
    0 references